Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis open label extension to a double-blind trialCasilda G. Black, Korn Jh, Mayes et al.|UCL Discovery (University College London)|2006Cited by 6
Functional correlates of reduction of digital ulcers by Bosentan therapy in patients with systemic sclerosis (SSC)Janet Pope, Seibold, Mayes et al.|UCL Discovery (University College London)|2006Cited by 0
Developing a Disease Activity and Therapeutic Response Index in Connective Tissue Disease Related Interstitial Lung Disease: Initial Results of a Delphi ExerciseL.A. Saketkoo, Seibold, Dörte Huscher et al.|UCL Discovery (University College London)|2011Cited by 0